Volume 78, Issue 6 pp. 1273-1278
ORIGINAL ARTICLE

Pilot and feasibility of the SMART IBD mobile app to improve self-management in pediatric inflammatory bowel disease

Kevin A. Hommel

Corresponding Author

Kevin A. Hommel

Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Center for Adherence and Self-Management, Cincinnati, Ohio, USA

Department of Pediatrics, University of Cincinnati College of Medicine, Birmington, Alabama, USA

Correspondence Kevin A. Hommel, 3333 Burnet Ave, MLC 7039, Cincinnati, OH 45229, USA.

Email: [email protected]

Search for more papers by this author
Amy E. Noser

Amy E. Noser

Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, USA

Search for more papers by this author
Jill Plevinsky

Jill Plevinsky

Children's Hospital of Philadelphia, Greenville, South Carolina, USA

Search for more papers by this author
Kate Gamwell

Kate Gamwell

Children's Hospital in the Upstate, University of South Carolina School of Medicine Greenville, Cincinnati, Ohio, USA

Search for more papers by this author
Lee A. Denson

Lee A. Denson

Department of Pediatrics, University of Cincinnati College of Medicine, Birmington, Alabama, USA

Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Birmington, Alabama, USA

Search for more papers by this author
First published: 29 April 2024
Citations: 3

Abstract

Objectives

Access to evidence-based self-management support in pediatric inflammatory bowel disease (IBD) is a significant challenge. Digital therapeutic solutions can increase access and provide data to patients and providers that would otherwise not be available. We have iteratively developed a mobile application, Self-Management Assistance with Recommended Treatment (SMART) IBD, that allows patients to access self-management support and record symptoms and medication adherence.

Methods

We conducted a pilot and feasibility study for this digital therapeutic tool in which patients used SMART IBD for 30 days.

Results

Results indicated that patients rated the app quality as good and accessed the app adequately overall, with some pages being used often. Medication adherence increased over the course of the study and was associated with sleep duration, mood, and stool consistency and blood content.

Conclusions

Overall, this study demonstrated adequate feasibility for the SMART IBD app and initial findings suggest that additional research is needed to explore the potential impact of this tool in clinical care.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.